Avsnitt
-
Professor Fadi Charchar on how lifestyle affects hypertension and what a patient could do to prevent hypertension and reduce then blood pressure.
Video: https://medicaldigest.org/scientific-contents/interview:how-lifestyle-affects-hypertension
-
Professor Jorie Versmissen and Professor Fadi Charchar discussed the ESH - ISH Joint Session on balancing common side effects of Thiazide/Thiazide-like diuretics through addition of other Blood Pressure lowering drugs.
Video: https://medicaldigest.org/scientific-contents/interview:esh-ish-joint-session-balancing-common-side-effects-thiazidethiazide-diuretics-through-addition-other-blood-pressure-lowering-drugs
-
Saknas det avsnitt?
-
Professor Ricardo Fontes-Carvalho on the role of beta-blockers in the treatment of hypertension and cardiologic diseases.
Video: https://medicaldigest.org/scientific-contents/interview:beta-blockers-hypertension-and-cvd
-
Professor Josep Redon chaired an interesting session on Diabetes and Metabolic risk factors at ESH 2024.
Video: https://medicaldigest.org/scientific-contents/interview:diabetes-and-metabolic-risk-factors
-
Professor Roland Schmieder, Co-Chair of ESH 2024 on the ESH 2024 Congress and the updated Guidelines.
Video: https://medicaldigest.org/scientific-contents/interview:esh-clinical-practice-guidelines
-
We asked Professor Antonio Almeida, the President of European Hematology Association about the benefits and perspectives in EHA as a European hematologist, about the highlights of this year EHA congress and about the new Guidelines.
Video: https://medicaldigest.org/scientific-contents/standalonecontent:haematology-forefront-interview-eha-president
-
Professor Vasilios Kotsis on obesity induced hypertension and its state of the art treatment.
Video: https://medicaldigest.org/scientific-contents/interview:obesity-induced-hypertension
-
Professor Roland Schmieder on the results of a prospective randomized sham-controlled study and explains the effects of renal denervation on blood pressure in patients with chronic kidney disease and uncontrolled hypertension
Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-beta-blocker-choice-influence-age-stress-and-co-morbidities
-
Professor Sverre Erik Kjeldsen at the recent annual meeting of the European Society of Hypertension, held a lecture on the role of beta-blockers in the management of hypertension.
Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-beta-blocker-choice-influence-age-stress-and-co-morbidities
-
Professor Francesca Mallamaci co-chaired a session at the current Annual Congress of the European Society of Hypertension on cardiovascular protective effects of SGLT-2 inhibitors. The new drug class revolutionized the treatment of type-2 diabetes. What did we learn in the clinical trials about these drugs regarding nephroprotection, CV protection in the diabetic population?
Video:
-
Professor Bryan Williams chaired an interesting symposium at ESH 2024. The joint ESH/ESC guideline on the diagnosis and treatment of hypertension and explained his thoughts on how to improve adherence in hypertension management.
Video: https://medicaldigest.org/scientific-contents/interview:time-act-improve-adherence-hypertension-management-bridging-gap-between-knowledge-and-action
-
Professor Claudio Borghi chaired a symposium at ESH 2024 on two very important patient groups, diabetic patients and coronary patients, on antihypertensive treatment.
Video: https://medicaldigest.org/scientific-contents/interview:real-life-hypertensive-patients-towards-holistic-approach-clinical-practice
-
Professor Sofie Brouwers explained at ESH 2024 that antihypertensive treatment for chronic coronary artery disease should be based on an ACE inhibitor and the evidence supporting this.
Video: https://medicaldigest.org/scientific-contents/interview:hypertension-and-cad-need-more-spcs-report-esh2024
-
Professor Thomas Hoffmann, Director of the Department of Otolaryngology and Head and Neck Surgery at the University of Ulm, raises awareness of the growing number of HPV-associated head and neck cancers in our interview. The right combination of treatment modalities - less and less invasive surgical procedures, increasingly precise radiotherapy options and systemic therapies, especially immunotherapies - can make a dramatic difference to disease outcomes, while the role of prophylactic HPV vaccination cannot be overemphasised.
Video: https://medicaldigest.org/scientific-contents/interview:hpv-associated-head-and-neck-cancers
-
Dr. Robert Sifrer, Director of the Department of Otolaryngology and Head and Neck Surgery at the University of Ljubljana, believes that the most important breakthrough in the treatment of head and neck cancer patients has been the recent development of immunotherapy, which is also helping patients with advanced stage cancer, and expects the importance of drug therapies to increase in the future. He was also asked about the problems of caring for patients with head and neck cancer in our interview at the International Danube Symposium on Otolaryngology.
Video: https://medicaldigest.org/scientific-contents/interview:breakthroughs-and-challenges-treatment-head-and-neck-cancer
-
Professor George D. Dangas chaired the Featured Clinical Research on Monday and shared his insights on the trials about acute coronary syndromes, atrial fibrillation related ablation procedures and aortic valve replacements.
- Fractional Flow Reserve-guided Complete Or Culprit-only PCI In Patients With ST-elevation Myocardial Infarction
- Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention In Acute Coronary Syndromes: The Multicenter, Randomized, Blinded, Ivus-acs Trial
- A Multicenter Prospective Randomized Study Comparing The Incidence Of Periprocedural Cerebral Embolisms Caused By Catheter Ablation Of Atrial Fibrillation Between Cryoballoon And Radiofrequency Ablation
- Protein And Exercise To Reverse Frailty In Older Men And Women Undergoing Transcatheter Aortic Valve Replacement: The PERFORM-TAVR Trial
- Transseptal Versus Retrograde Aortic Ventricular Entry To Reduce Systemic Emboli (the TRAVERSE Trial)
Video: https://medicaldigest.org/scientific-contents/interview:featured-clinical-researches-acute-coronary-syndromes-atrial-fibrillation-related-ablation-procedures-and-aortic-valve-replacements
- Visa fler